MEKK3 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-MEKK3 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMEKK3
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat, sheep, dog, porcine, monkey, Drosophila, guinea pig, hamster, rabbit, Xenopus
Isotypen/a
Formatunconjugated
Size0.1 mL
Concentrationn/a
ApplicationsImmunohistochemistry (IHC), Immunohistochemistry (IHC) Paraffin, Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRecognizes human, mouse, rat, dog, Drosophila, guinea pig, hamster, monkey, pig, rabbit, sheep and Xenopus MEKK3. MEKKs (Mitogen activated protein kinase kinase kinases) are serine-threonine kinases that act as the first tier of cellular MAP kinase pathways by activation of MAP/ERK kinases, or MEKs. Many enzymes with MEKK activity have been identified, including MEKK1-4, Raf, MLK3, TAK, and DLK. MEKKs generally display little similarity outside of their catalytic kinase domains. MEKK1-4 are nearly 50% identical within their catalytic domains, and are known to regulate Erk, Jnk, and p38 MAP kinase pathways. MEKK2 and MEKK3 bind MEK5 via conserved PB1 domains, leading to downstream activation of Erk5.
ImmunogenImmunogen: Synthetic peptide corresponding to the sequence near the N-terminus of mouse MEKK3.
Other Names[MAP3K3; MEK kinase 3; MEKK3, pAb], [Map3k3; Map3k3; Mekk3; MAPKKK3; AW548911; mKIAA4031; Mekk3; MEK kinase 3; MEKK 3]
Gene, Accession #[MEKK3], Gene ID: 26406, NCBI: Q61084.1, UniProt: Q61084
Catalog #MBS565725
Price$345
Order / More InfoMEKK3 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.